Evidence map›Paper›PMID 35069593›Full record

ArticleFrontiers in immunology2021

Treatment of Severe Japanese Encephalitis Complicated With Hashimoto's Thyroiditis and Guillain-Barré Syndrome With Protein A Immunoadsorption: A Case Report.

Qiuling Zang, Yating Wang, Junshuang Guo, Liyang Long, Shuyu Zhang, Can Cui, Dandan Song, Boguang Yu, Fenlan Tang, Junfang Teng and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Predictive effect of the decline in CD4Frontiers in neurology · 2023
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Qiuling ZangNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yating WangNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Junshuang GuoNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Liyang LongTraditional Chinese Medicine Hospital of Qiandongnan Miao and Dong Autonomous Prefecture, Kaili, China.
Shuyu ZhangNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Can CuiNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Dandan SongNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Boguang YuGuangdong Provincial Key Laboratory of Hemoadsorption Technology, Guangzhou, China.
Fenlan TangGuangdong Provincial Key Laboratory of Hemoadsorption Technology, Guangzhou, China.
Junfang TengNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang MiaoNeuro-intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
First Affiliated Hospital of Zhengzhou University · CNKey Laboratory of Guangdong Province · CNAnyang Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A severely comatose female patient was diagnosed with Japanese encephalitis (JE). Her condition was complicated by Hashimoto's thyroiditis (HT) and Guillain-Barré syndrome (GBS). After antiviral, glucocorticoid, and immunoglobulin treatment, the patient's consciousness was restored, and she could breathe spontaneously. Following this, new-onset, primarily demyelinating GBS developed, which progressed to demyelination combined with axonal injury. The patient was switched to protein A immunoadsorption (PAIA) therapy, and her Hughes score decreased rapidly, from 4 to 1 after 6 months. This patient is the first to receive PAIA combined with an antiviral-glucocorticoid-immunoglobulin regimen to treat encephalitis, meningitis, HT, and GBS caused by JE infection, thereby reflecting the importance of clinical application of PAIA in the treatment of immunological complications of JE.

Indexed as

PlasmapheresisStaphylococcal Protein AAdultBiomarkersDisease ManagementEncephalitis, JapaneseFemaleGuillain-Barre SyndromeHashimoto DiseaseHumansMagnetic Resonance ImagingSeverity of Illness IndexSymptom AssessmentTomography, X-Ray ComputedTreatment OutcomeBiomarkersStaphylococcal Protein Acase reportGuillain-Barré syndromeHashimoto’s thyroiditisJapanese encephalitisprotein A immunoadsorption

Identifiers

PMID35069593
PMCPMC8777188
OpenAlexW4206209232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.